Latest news
September 30, 2026
Australia produces world-class research, but many university startups still struggle to secure the growth capital needed to scale. UniQuest CEO Dr Dean Moss explores whether Australia's challenge is a shortage of capital, or a shortage of appetite for risk.
September 23, 2026
Two UQ research teams supported by UniQuest have secured $4 million in CUREator+ funding to advance potential new therapies for Alzheimer’s disease and dementia, accelerating the journey from laboratory discovery towards clinical development.
September 21, 2026
A homegrown vaccine platform demonstrated in animals could soon become a ‘plug-and-play’ system to rapidly adapt to future mosquito-borne disease threats in humans.
June 19, 2026
A promising new treatment for advanced and therapy-resistant prostate cancer developed from research conducted at The University of Queensland has taken a major step towards the clinic.
April 30, 2026
Australian cattle producers can more accurately determine whether animals in their herd will grow horns thanks to a new genetic test developed using University of Queensland research.
February 24, 2026
A discovery made at The University of Queensland using blood-clotting proteins found in Australian snake venoms has been translated into a pathology product in Japan.
November 5, 2025
UQ Physiotherapy lecturer Dr Georgina Clutterbuck started Sports Stars, an allied health intervention that helps children with a disability be involved in sport, from the grassroots at a park in Ipswich.
October 24, 2025
UniQuest Board Director Anne-Marie Birkill has received a Vice-Chancellor's Alumni Excellence Award
September 9, 2025
A plug-and-play device that makes industry-grade hydrogen peroxide at higher concentrations could transform how one of the world’s most widely used chemicals is produced.
August 19, 2025
Lucia Bio Pty Ltd, a Molecule to Medicine portfolio biotechnology company focused on the development of best-in-class spleen tyrosine kinase (Syk) inhibitors for a range of immune-mediated diseases, today announced it has raised AU$2 million in seed financing.
July 22, 2025
Acquisition of a biopharmaceutical company commercialising The University of Queensland’s Molecular Clamp technology has been agreed by one of the world’s leading healthcare companies in a landmark up to US$1.6 billion deal.
July 1, 2025
The UniQuest teams' key insights into evolving trends in therapeutic development and what's piquing pharma interest at the BIO International Convention held in June in Boston, USA.
May 13, 2025
A $1.25 million investment is driving the development of a new treatment for advanced and therapy-resistant prostate cancer at The University of Queensland.
March 4, 2025
A new startup aimed at discovering and developing anti-inflammatory disease medicines has been formed by The University of Queensland’s commercialisation arm UniQuest and global biotech company Molecule to Medicine (MTM).
February 17, 2025
Inaccessible supplies of an element crucial to powering a clean-energy future are set to be unlocked with technology developed by The University of Queensland.
December 17, 2024
A promising ultrasound therapy to potentially restore brain function in people with Alzheimer’s disease has been licenced to a new start-up spun out of The University of Queensland.
December 10, 2024
A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queensland has produced successful results in a human clinical trial.
November 29, 2024
A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development.
November 15, 2024
A Brisbane-based software start-up using AI to improve road safety and traffic management has been acquired by Canadian company Transoft Solutions.
November 8, 2024
The University of Queensland’s capabilities in drug discovery and development are set to be strengthened by a new partnership between UniQuest and global biotech company Molecule to Medicine (MTM).
November 1, 2024
A $32 million University of Queensland venture capital fund is boosting the state’s startup ecosystem, with a Brisbane company developing medical robotics among the first beneficiaries.
October 30, 2024
Victorian therapeutics incubator BioCurate is partnering with UniQuest’s small molecule drug discovery and development engine QEDDI to develop a new effective treatment for neuropathic pain with potential to become a safe alternative to opioids.
October 9, 2024
A tissue-culture propagation technology developed at The University of Queensland to grow hundreds of plants from a single cutting is set to bolster avocado production across Latin America to meet growing demand.
July 31, 2024
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic discovery capability under the leadership of Therapeutic Innovation Australia (TIA).
May 27, 2024
Experienced venture capitalist, innovation and entrepreneurship advisor Anne-Marie Birkill has joined the UniQuest Board of Directors.
May 7, 2024
A new diagnostic and treatment approach for bladder cancer will undergo a clinical trial in Queensland.
April 23, 2024
A University of Queensland founded startup that builds exhibition design software for art galleries, museums and theatres has been acquired by Swiss company Culture Software Group.
February 20, 2024
A tech start-up from The University of Queensland is set to make efficiencies in the renewable energy sector by detecting faults in solar farm panels.
December 20, 2023
UniQuest, the commercialisation company of The University of Queensland (UQ) has announced that Mr Andrew Morgan, an experienced corporate adviser, has joined its board of directors.
October 31, 2023
The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.
September 21, 2023
University of Queensland researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients.
September 13, 2023
A tool developed by researchers at The University of Queensland that measures floodwater depth and velocity will be sold globally after it was licensed to a US-based company.
September 11, 2023
Researchers are appealing for funding to launch clinical trials into a novel drug which could prevent and treat skin cancer in transplant patients.
May 24, 2023
A promising treatment for inflammatory bowel disease and a pre-clinical drug candidate for a devastating neurological condition are among four University of Queensland (UQ) research projects to receive support from Australia’s national biotech incubator – CUREator.
February 21, 2023
A University of Queensland (UQ) spin-out company will use the traditional Indigenous knowledge of spinifex from the Queensland outback to develop innovative medical gels.
October 26, 2022
Associate Professor Sumaira Hasnain and Jetra Therapeutics Pty Ltd have won the 2022 UniQuest Commercialisation Award.
September 27, 2022
Global biopharmaceutical company Pfizer has acquired University of Queensland startup ResApp Health Limited for $179 million.
September 26, 2022
A leadership development program created by researchers at The University of Queensland (UQ) is set to create impact for organisations around the world.
September 14, 2022
The successful Medical Research Future Fund (MRFF) funded Biomedical Translation Bridge (BTB) Program has successfully concluded after supporting 21 therapeutic and medical device projects towards commercialisation.
August 24, 2022
UniQuest, the commercialisation company of The University of Queensland (UQ), has welcomed the appointment of Professor Mark Blows to its Board.
July 20, 2022
UQ research into developing new treatments for conditions such as cancer, inflammatory diseases and type 1 diabetes has received recognition and funding support from a national incubator for biomedical startup companies.
July 4, 2022
A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane start-up.
April 13, 2022
A skin microbiopsy device developed by researchers at The University of Queensland, that takes tissue samples smaller than 0.5mm in diameter, could change the way skin cancers and other skin conditions are diagnosed and monitored.
April 5, 2022
A Brisbane startup company founded on University of Queensland technology to monitor the health of electricity network transformers has been acquired by French multinational Schneider Electric in a multi-million-dollar deal.
March 23, 2022
Unlocking the mystery behind the catastrophic death of nerve cells in neurodegenerative disease is driving University of Queensland researcher Dr Adam Walker and his team to new heights in the fight against motor neuron disease (MND) and frontotemporal dementia.
December 2, 2021
A University of Queensland start-up company developing rapid serum blood collection tube technology will be manufactured and used in Japan after it partnered with the country’s leading medical device company, Terumo Corporation.
November 19, 2021
UniQuest, the University of Queensland’s commercialisation company, has announced it has entered into a license agreement with PreveCeutical Medical Inc. (“PreveCeutical”) (CSE: PREV, OTCQB: PRVCF, FSE: 18H), granting rights to its Sol-Gel technology solely for the delivery of cannabinoids.
October 20, 2021
A University of Queensland (UQ) start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
September 23, 2021
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls with translating drugs such as chloroquine, hydroxychloroquine, ivermectin and similar compounds to treat COVID-19, say a team of experts.
September 22, 2021
Australia may soon have the jump on cane toads after a Gold Coast not-for-profit was granted an exclusive licence to market a University of Queensland-designed lure for the invasive pests.
